ImmPACT Bio Announces Completion of Merger with Kalthera to Progress Next-Generation CAR T Therapies for the Treatment of Cancer

CAMARILLO, Calif., July 22, 2021 /PRNewswire/ -- ImmPACT Bio USA, Inc., a company developing novel cell therapies for treating cancer, today announced its merger with Kalthera, Inc., a biotechnology company. Kalthera is currently progressing a clinical trial at the University of...

from PR Newswire: https://ift.tt/3hTdpJw